DL
Insider
Daniel D. Long
SVP, Drug DiscoveryDaniel D. Long (SVP, Drug Discovery) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Septerna, Inc. (SEPN). The largest single filing was $533K of SEPN (15,000 sh across 2 lots, as filed), executed Jun 22.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$659K
shares × price, as filed
Last traded
Sep 1
Filed Sep 3
Median ADV $19.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $659K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
SEPNRecent filings
SEPNSALE
Septerna, Inc.
View filing →
$126K3,333 sh × $37.83
Exec Sep 1
Filed Sep 3 · 7:01 PM ET SEPNSALE Septerna, Inc. View filing → $533K
15,000 sh across 2 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET